These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 29723898)

  • 1. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.
    Marchesini G; Avagnina S; Barantani EG; Ciccarone AM; Corica F; Dall'Aglio E; Dalle Grave R; Morpurgo PS; Tomasi F; Vitacolonna E
    J Endocrinol Invest; 2005 Apr; 28(4):333-9. PubMed ID: 15966506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of adiponectin in patients with type 2 diabetes with nonalcoholic fatty liver disease depending on transaminases level].
    Mykhal'chyshyn HP; Bodnar PM; Kobyliak NM
    Lik Sprava; 2014; (5-6):130-8. PubMed ID: 25906661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
    Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
    Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers.
    Sesti G; Fiorentino TV; Hribal ML; Sciacqua A; Perticone F
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1182-7. PubMed ID: 23419734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Zhang Y; Lu X; Hong J; Chao M; Gu W; Wang W; Ning G
    Endocrine; 2010 Oct; 38(2):181-7. PubMed ID: 20972737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
    Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?
    Sargin M; Uygur-Bayramiçli O; Sargin H; Orbay E; Yayla A
    J Clin Gastroenterol; 2003; 37(5):399-402. PubMed ID: 14564188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
    Ricci G; Bersani G; Rossi A; Pigò F; De Fabritiis G; Alvisi V
    Obes Surg; 2008 Nov; 18(11):1438-42. PubMed ID: 18369681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).
    Parrinello CM; Rudolph BJ; Lazo M; Gallo LC; Thyagarajan B; Cotler SJ; Qi Q; Seeherunvong T; Vidot DC; Strickler HD; Kaplan RC; Isasi CR
    J Clin Gastroenterol; 2019 Feb; 53(2):e46-e53. PubMed ID: 29099463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
    Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
    Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.